Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

NCT01251250 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lost sponsor support

Conditions

Refractory Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia

Interventions

OTHER: laboratory biomarker analysis
GENETIC: western blotting
GENETIC: gene expression analysis
OTHER: pharmacological study
OTHER: flow cytometry
GENETIC: fluorescence in situ hybridization
BIOLOGICAL: azadirachta indica
GENETIC: reverse transcriptase-polymerase chain reaction

Sponsor

Roswell Park Cancer Institute